Amazon Facemasks

Preprint: Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the emergence of the Omicron variant

BA.1, BA.2, Children, Coronavirus, Deaths, Hospitalization, Infection, Omicron, Pfizer/Biontech, Reinfection, Revaccination, Side Effects, Vaccine, Vaccine Waning

For children 5-11, VE against cases declined from 65% to 12% by 28-34 days. In the Omicron era, the effectiveness against cases of BNT162b2 declined rapidly for children, particularly those 5-11 years.

However, vaccination of children 5-11 years was protective against severe disease and is recommended. These results highlight the potential need to study alternative vaccine dosing for children and the continued importance layered protections, including mask wearing, to prevent infection and transmission.

Preprint: Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the emergence of the Omicron variant

 

 

Preprint: Intracellular Reverse Transcription into DNA of mRNA Vaccine

 

 

 

Photo by charlesdeluvio on Unsplash

** This post was originally published on February 28, 2022 **